Keywords :
Calcium/physiology; Calcium Signaling/physiology; Carcinoma, Hepatocellular; Cell Hypoxia; Cloning, Molecular; DNA-Binding Proteins/drug effects/genetics/metabolism; Gene Expression Regulation, Neoplastic/drug effects; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Ionomycin/pharmacology; Liver Neoplasms; MAP Kinase Signaling System/physiology; Mitogen-Activated Protein Kinases/metabolism; Nuclear Proteins/drug effects/genetics/metabolism; Plasmids; Transcription Factors/metabolism; Transfection; Tumor Cells, Cultured
Abstract :
[en] HIF-1 (hypoxia-inducible factor-1) is the main transcription factor responsible for increased gene expression in hypoxia. The oxygen-dependent regulation of HIF-1 activity occurs at multiple levels in vivo. The mechanisms regulating HIF-1alpha protein expression have been most extensively analyzed, but the ones modulating HIF-1 transcriptional activity remain unclear. Changes in the phosphorylation and/or redox status of HIF-1alpha certainly play a role. Here, we show that ionomycin could activate HIF-1 transcriptional activity in a way that is additive to the effect of hypoxia without affecting HIF-1alpha protein level and HIF-1 DNA binding capacity. In addition, a calmodulin dominant-negative mutant as well as BAPTA, an intracellular calcium chelator, inhibited the hypoxia-induced HIF-1 activation. These results indicate that elevated calcium in hypoxia could participate in HIF-1 activation. PD98059, an inhibitor of the ERK pathway, but not KN-93, an inhibitor of calmodulin kinases II and IV, also blocked HIF-1 activation by hypoxia and by ionomycin. Altogether, these results suggest that calcium and calmodulin would act upstream of ERK in the hypoxia signal transduction pathway leading to enhanced HIF-1 transcriptional activity.
Scopus citations®
without self-citations
53